nodes	percent_of_prediction	percent_of_DWPC	metapath
Amoxapine—ORM1—Vandetanib—thyroid cancer	0.329	0.443	CbGbCtD
Amoxapine—HTR2B—Sorafenib—thyroid cancer	0.211	0.284	CbGbCtD
Amoxapine—HTR2C—Sorafenib—thyroid cancer	0.137	0.185	CbGbCtD
Amoxapine—CYP2D6—Sorafenib—thyroid cancer	0.0411	0.0553	CbGbCtD
Amoxapine—CYP2D6—Doxorubicin—thyroid cancer	0.0249	0.0336	CbGbCtD
Amoxapine—Atrial fibrillation—Vandetanib—thyroid cancer	0.00303	0.0221	CcSEcCtD
Amoxapine—Pancreatitis—Vandetanib—thyroid cancer	0.00243	0.0177	CcSEcCtD
Amoxapine—Gynaecomastia—Sorafenib—thyroid cancer	0.00239	0.0174	CcSEcCtD
Amoxapine—Pollakiuria—Vandetanib—thyroid cancer	0.00229	0.0167	CcSEcCtD
Amoxapine—Stomatitis—Vandetanib—thyroid cancer	0.00216	0.0157	CcSEcCtD
Amoxapine—Alopecia—Vandetanib—thyroid cancer	0.00175	0.0128	CcSEcCtD
Amoxapine—Dysgeusia—Vandetanib—thyroid cancer	0.00169	0.0123	CcSEcCtD
Amoxapine—Lacrimation—Epirubicin—thyroid cancer	0.00168	0.0122	CcSEcCtD
Amoxapine—Pancreatitis—Sorafenib—thyroid cancer	0.00164	0.012	CcSEcCtD
Amoxapine—Vision blurred—Vandetanib—thyroid cancer	0.00163	0.0119	CcSEcCtD
Amoxapine—Tremor—Vandetanib—thyroid cancer	0.00162	0.0118	CcSEcCtD
Amoxapine—Lacrimation—Doxorubicin—thyroid cancer	0.00155	0.0113	CcSEcCtD
Amoxapine—Erectile dysfunction—Sorafenib—thyroid cancer	0.00154	0.0112	CcSEcCtD
Amoxapine—Loss of consciousness—Vandetanib—thyroid cancer	0.00152	0.0111	CcSEcCtD
Amoxapine—Convulsion—Vandetanib—thyroid cancer	0.0015	0.0109	CcSEcCtD
Amoxapine—Hypertension—Vandetanib—thyroid cancer	0.00149	0.0109	CcSEcCtD
Amoxapine—Acute coronary syndrome—Sorafenib—thyroid cancer	0.00147	0.0107	CcSEcCtD
Amoxapine—Myocardial infarction—Sorafenib—thyroid cancer	0.00146	0.0107	CcSEcCtD
Amoxapine—Stomatitis—Sorafenib—thyroid cancer	0.00145	0.0106	CcSEcCtD
Amoxapine—Jaundice—Sorafenib—thyroid cancer	0.00145	0.0106	CcSEcCtD
Amoxapine—Dry mouth—Vandetanib—thyroid cancer	0.00144	0.0105	CcSEcCtD
Amoxapine—Oedema—Vandetanib—thyroid cancer	0.00141	0.0103	CcSEcCtD
Amoxapine—Thrombocytopenia—Vandetanib—thyroid cancer	0.00138	0.0101	CcSEcCtD
Amoxapine—Insomnia—Vandetanib—thyroid cancer	0.00128	0.0093	CcSEcCtD
Amoxapine—Paraesthesia—Vandetanib—thyroid cancer	0.00127	0.00923	CcSEcCtD
Amoxapine—Tinnitus—Sorafenib—thyroid cancer	0.00125	0.0091	CcSEcCtD
Amoxapine—Dyspepsia—Vandetanib—thyroid cancer	0.00124	0.00905	CcSEcCtD
Amoxapine—Decreased appetite—Vandetanib—thyroid cancer	0.00123	0.00894	CcSEcCtD
Amoxapine—Fatigue—Vandetanib—thyroid cancer	0.00122	0.00887	CcSEcCtD
Amoxapine—Constipation—Vandetanib—thyroid cancer	0.00121	0.00879	CcSEcCtD
Amoxapine—Petechiae—Epirubicin—thyroid cancer	0.0012	0.00873	CcSEcCtD
Amoxapine—Alopecia—Sorafenib—thyroid cancer	0.00118	0.00863	CcSEcCtD
Amoxapine—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00115	0.00841	CcSEcCtD
Amoxapine—Dysgeusia—Sorafenib—thyroid cancer	0.00114	0.00832	CcSEcCtD
Amoxapine—Abdominal pain—Vandetanib—thyroid cancer	0.00111	0.00813	CcSEcCtD
Amoxapine—Body temperature increased—Vandetanib—thyroid cancer	0.00111	0.00813	CcSEcCtD
Amoxapine—Petechiae—Doxorubicin—thyroid cancer	0.00111	0.00808	CcSEcCtD
Amoxapine—Lacrimation increased—Epirubicin—thyroid cancer	0.00107	0.0078	CcSEcCtD
Amoxapine—Syncope—Sorafenib—thyroid cancer	0.00105	0.00762	CcSEcCtD
Amoxapine—Leukopenia—Sorafenib—thyroid cancer	0.00104	0.00761	CcSEcCtD
Amoxapine—Loss of consciousness—Sorafenib—thyroid cancer	0.00102	0.00747	CcSEcCtD
Amoxapine—Atrioventricular block—Epirubicin—thyroid cancer	0.00102	0.00741	CcSEcCtD
Amoxapine—Asthenia—Vandetanib—thyroid cancer	0.00101	0.00738	CcSEcCtD
Amoxapine—Hypertension—Sorafenib—thyroid cancer	0.00101	0.00734	CcSEcCtD
Amoxapine—Coordination abnormal—Epirubicin—thyroid cancer	0.001	0.00732	CcSEcCtD
Amoxapine—Pruritus—Vandetanib—thyroid cancer	0.000998	0.00728	CcSEcCtD
Amoxapine—Lacrimation increased—Doxorubicin—thyroid cancer	0.000989	0.00721	CcSEcCtD
Amoxapine—Dry mouth—Sorafenib—thyroid cancer	0.000971	0.00708	CcSEcCtD
Amoxapine—Diarrhoea—Vandetanib—thyroid cancer	0.000965	0.00704	CcSEcCtD
Amoxapine—Atrioventricular block—Doxorubicin—thyroid cancer	0.00094	0.00685	CcSEcCtD
Amoxapine—Shock—Sorafenib—thyroid cancer	0.000936	0.00682	CcSEcCtD
Amoxapine—Dizziness—Vandetanib—thyroid cancer	0.000933	0.0068	CcSEcCtD
Amoxapine—Thrombocytopenia—Sorafenib—thyroid cancer	0.000931	0.00679	CcSEcCtD
Amoxapine—Coordination abnormal—Doxorubicin—thyroid cancer	0.000929	0.00677	CcSEcCtD
Amoxapine—Anorexia—Sorafenib—thyroid cancer	0.000907	0.00661	CcSEcCtD
Amoxapine—Vomiting—Vandetanib—thyroid cancer	0.000897	0.00654	CcSEcCtD
Amoxapine—Rash—Vandetanib—thyroid cancer	0.000889	0.00648	CcSEcCtD
Amoxapine—Dermatitis—Vandetanib—thyroid cancer	0.000888	0.00648	CcSEcCtD
Amoxapine—Headache—Vandetanib—thyroid cancer	0.000883	0.00644	CcSEcCtD
Amoxapine—Mental disability—Epirubicin—thyroid cancer	0.000855	0.00624	CcSEcCtD
Amoxapine—Nausea—Vandetanib—thyroid cancer	0.000838	0.00611	CcSEcCtD
Amoxapine—Dyspepsia—Sorafenib—thyroid cancer	0.000837	0.00611	CcSEcCtD
Amoxapine—Decreased appetite—Sorafenib—thyroid cancer	0.000827	0.00603	CcSEcCtD
Amoxapine—Fatigue—Sorafenib—thyroid cancer	0.00082	0.00598	CcSEcCtD
Amoxapine—Constipation—Sorafenib—thyroid cancer	0.000814	0.00593	CcSEcCtD
Amoxapine—Vascular purpura—Epirubicin—thyroid cancer	0.0008	0.00583	CcSEcCtD
Amoxapine—Mental disability—Doxorubicin—thyroid cancer	0.000791	0.00577	CcSEcCtD
Amoxapine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000778	0.00567	CcSEcCtD
Amoxapine—Increased appetite—Epirubicin—thyroid cancer	0.000761	0.00555	CcSEcCtD
Amoxapine—Urticaria—Sorafenib—thyroid cancer	0.000756	0.00551	CcSEcCtD
Amoxapine—Abdominal pain—Sorafenib—thyroid cancer	0.000752	0.00548	CcSEcCtD
Amoxapine—Body temperature increased—Sorafenib—thyroid cancer	0.000752	0.00548	CcSEcCtD
Amoxapine—Purpura—Epirubicin—thyroid cancer	0.000742	0.00541	CcSEcCtD
Amoxapine—Vascular purpura—Doxorubicin—thyroid cancer	0.00074	0.00539	CcSEcCtD
Amoxapine—Cerebrovascular accident—Epirubicin—thyroid cancer	0.00073	0.00532	CcSEcCtD
Amoxapine—Increased appetite—Doxorubicin—thyroid cancer	0.000704	0.00514	CcSEcCtD
Amoxapine—Purpura—Doxorubicin—thyroid cancer	0.000687	0.00501	CcSEcCtD
Amoxapine—Asthenia—Sorafenib—thyroid cancer	0.000683	0.00498	CcSEcCtD
Amoxapine—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.000675	0.00492	CcSEcCtD
Amoxapine—Pruritus—Sorafenib—thyroid cancer	0.000673	0.00491	CcSEcCtD
Amoxapine—Ataxia—Epirubicin—thyroid cancer	0.000673	0.0049	CcSEcCtD
Amoxapine—Diarrhoea—Sorafenib—thyroid cancer	0.000651	0.00475	CcSEcCtD
Amoxapine—Dizziness—Sorafenib—thyroid cancer	0.000629	0.00459	CcSEcCtD
Amoxapine—HTR7—neck—thyroid cancer	0.000624	0.0569	CbGeAlD
Amoxapine—Ataxia—Doxorubicin—thyroid cancer	0.000622	0.00454	CcSEcCtD
Amoxapine—Eosinophilia—Epirubicin—thyroid cancer	0.000612	0.00446	CcSEcCtD
Amoxapine—Pancreatitis—Epirubicin—thyroid cancer	0.000606	0.00442	CcSEcCtD
Amoxapine—Vomiting—Sorafenib—thyroid cancer	0.000605	0.00441	CcSEcCtD
Amoxapine—Rash—Sorafenib—thyroid cancer	0.0006	0.00437	CcSEcCtD
Amoxapine—Dermatitis—Sorafenib—thyroid cancer	0.000599	0.00437	CcSEcCtD
Amoxapine—Headache—Sorafenib—thyroid cancer	0.000596	0.00435	CcSEcCtD
Amoxapine—DRD3—head—thyroid cancer	0.000589	0.0537	CbGeAlD
Amoxapine—CHRM1—saliva-secreting gland—thyroid cancer	0.000571	0.0521	CbGeAlD
Amoxapine—Pollakiuria—Epirubicin—thyroid cancer	0.000571	0.00416	CcSEcCtD
Amoxapine—HTR6—head—thyroid cancer	0.000567	0.0517	CbGeAlD
Amoxapine—Eosinophilia—Doxorubicin—thyroid cancer	0.000566	0.00413	CcSEcCtD
Amoxapine—Nausea—Sorafenib—thyroid cancer	0.000565	0.00412	CcSEcCtD
Amoxapine—Weight increased—Epirubicin—thyroid cancer	0.000563	0.0041	CcSEcCtD
Amoxapine—Pancreatitis—Doxorubicin—thyroid cancer	0.000561	0.00409	CcSEcCtD
Amoxapine—Drowsiness—Epirubicin—thyroid cancer	0.000551	0.00402	CcSEcCtD
Amoxapine—Stomatitis—Epirubicin—thyroid cancer	0.000537	0.00392	CcSEcCtD
Amoxapine—Jaundice—Epirubicin—thyroid cancer	0.000537	0.00392	CcSEcCtD
Amoxapine—Pollakiuria—Doxorubicin—thyroid cancer	0.000528	0.00385	CcSEcCtD
Amoxapine—Weight increased—Doxorubicin—thyroid cancer	0.000521	0.0038	CcSEcCtD
Amoxapine—Agranulocytosis—Epirubicin—thyroid cancer	0.000514	0.00375	CcSEcCtD
Amoxapine—Drowsiness—Doxorubicin—thyroid cancer	0.00051	0.00372	CcSEcCtD
Amoxapine—Stomatitis—Doxorubicin—thyroid cancer	0.000497	0.00363	CcSEcCtD
Amoxapine—Jaundice—Doxorubicin—thyroid cancer	0.000497	0.00363	CcSEcCtD
Amoxapine—Hepatitis—Epirubicin—thyroid cancer	0.000495	0.00361	CcSEcCtD
Amoxapine—Hypoaesthesia—Epirubicin—thyroid cancer	0.000492	0.00359	CcSEcCtD
Amoxapine—Agranulocytosis—Doxorubicin—thyroid cancer	0.000476	0.00347	CcSEcCtD
Amoxapine—Tinnitus—Epirubicin—thyroid cancer	0.000461	0.00336	CcSEcCtD
Amoxapine—Hepatitis—Doxorubicin—thyroid cancer	0.000458	0.00334	CcSEcCtD
Amoxapine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000456	0.00332	CcSEcCtD
Amoxapine—CHRM1—trachea—thyroid cancer	0.000441	0.0402	CbGeAlD
Amoxapine—Alopecia—Epirubicin—thyroid cancer	0.000437	0.00319	CcSEcCtD
Amoxapine—Tinnitus—Doxorubicin—thyroid cancer	0.000427	0.00311	CcSEcCtD
Amoxapine—Flatulence—Epirubicin—thyroid cancer	0.000424	0.0031	CcSEcCtD
Amoxapine—Tension—Epirubicin—thyroid cancer	0.000423	0.00308	CcSEcCtD
Amoxapine—Dysgeusia—Epirubicin—thyroid cancer	0.000422	0.00308	CcSEcCtD
Amoxapine—DRD1—head—thyroid cancer	0.000422	0.0384	CbGeAlD
Amoxapine—Nervousness—Epirubicin—thyroid cancer	0.000418	0.00305	CcSEcCtD
Amoxapine—HTR3A—head—thyroid cancer	0.000407	0.0371	CbGeAlD
Amoxapine—Vision blurred—Epirubicin—thyroid cancer	0.000406	0.00296	CcSEcCtD
Amoxapine—Alopecia—Doxorubicin—thyroid cancer	0.000405	0.00295	CcSEcCtD
Amoxapine—Agitation—Epirubicin—thyroid cancer	0.000396	0.00289	CcSEcCtD
Amoxapine—Flatulence—Doxorubicin—thyroid cancer	0.000393	0.00286	CcSEcCtD
Amoxapine—Tension—Doxorubicin—thyroid cancer	0.000391	0.00285	CcSEcCtD
Amoxapine—Dysgeusia—Doxorubicin—thyroid cancer	0.00039	0.00285	CcSEcCtD
Amoxapine—HTR2A—neck—thyroid cancer	0.000389	0.0355	CbGeAlD
Amoxapine—Nervousness—Doxorubicin—thyroid cancer	0.000387	0.00282	CcSEcCtD
Amoxapine—Syncope—Epirubicin—thyroid cancer	0.000386	0.00282	CcSEcCtD
Amoxapine—Leukopenia—Epirubicin—thyroid cancer	0.000386	0.00281	CcSEcCtD
Amoxapine—Palpitations—Epirubicin—thyroid cancer	0.000381	0.00278	CcSEcCtD
Amoxapine—Loss of consciousness—Epirubicin—thyroid cancer	0.000379	0.00276	CcSEcCtD
Amoxapine—Vision blurred—Doxorubicin—thyroid cancer	0.000376	0.00274	CcSEcCtD
Amoxapine—HTR7—trachea—thyroid cancer	0.000375	0.0342	CbGeAlD
Amoxapine—Convulsion—Epirubicin—thyroid cancer	0.000373	0.00272	CcSEcCtD
Amoxapine—Hypertension—Epirubicin—thyroid cancer	0.000372	0.00271	CcSEcCtD
Amoxapine—Agitation—Doxorubicin—thyroid cancer	0.000366	0.00267	CcSEcCtD
Amoxapine—Dry mouth—Epirubicin—thyroid cancer	0.000359	0.00262	CcSEcCtD
Amoxapine—Syncope—Doxorubicin—thyroid cancer	0.000357	0.00261	CcSEcCtD
Amoxapine—Leukopenia—Doxorubicin—thyroid cancer	0.000357	0.0026	CcSEcCtD
Amoxapine—Confusional state—Epirubicin—thyroid cancer	0.000354	0.00258	CcSEcCtD
Amoxapine—Palpitations—Doxorubicin—thyroid cancer	0.000352	0.00257	CcSEcCtD
Amoxapine—Oedema—Epirubicin—thyroid cancer	0.000352	0.00256	CcSEcCtD
Amoxapine—Loss of consciousness—Doxorubicin—thyroid cancer	0.00035	0.00255	CcSEcCtD
Amoxapine—HTR2B—thyroid gland—thyroid cancer	0.000347	0.0316	CbGeAlD
Amoxapine—Shock—Epirubicin—thyroid cancer	0.000346	0.00252	CcSEcCtD
Amoxapine—Convulsion—Doxorubicin—thyroid cancer	0.000345	0.00252	CcSEcCtD
Amoxapine—Thrombocytopenia—Epirubicin—thyroid cancer	0.000344	0.00251	CcSEcCtD
Amoxapine—Hypertension—Doxorubicin—thyroid cancer	0.000344	0.00251	CcSEcCtD
Amoxapine—Tachycardia—Epirubicin—thyroid cancer	0.000343	0.0025	CcSEcCtD
Amoxapine—HTR1B—head—thyroid cancer	0.000342	0.0311	CbGeAlD
Amoxapine—GABRA1—head—thyroid cancer	0.000342	0.0311	CbGeAlD
Amoxapine—SLC6A3—head—thyroid cancer	0.000339	0.0309	CbGeAlD
Amoxapine—Anorexia—Epirubicin—thyroid cancer	0.000335	0.00244	CcSEcCtD
Amoxapine—Dry mouth—Doxorubicin—thyroid cancer	0.000332	0.00242	CcSEcCtD
Amoxapine—Hypotension—Epirubicin—thyroid cancer	0.000329	0.0024	CcSEcCtD
Amoxapine—Confusional state—Doxorubicin—thyroid cancer	0.000328	0.00239	CcSEcCtD
Amoxapine—HTR2C—head—thyroid cancer	0.000328	0.0299	CbGeAlD
Amoxapine—Oedema—Doxorubicin—thyroid cancer	0.000325	0.00237	CcSEcCtD
Amoxapine—Shock—Doxorubicin—thyroid cancer	0.00032	0.00233	CcSEcCtD
Amoxapine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000319	0.00232	CcSEcCtD
Amoxapine—Insomnia—Epirubicin—thyroid cancer	0.000318	0.00232	CcSEcCtD
Amoxapine—Tachycardia—Doxorubicin—thyroid cancer	0.000317	0.00232	CcSEcCtD
Amoxapine—Paraesthesia—Epirubicin—thyroid cancer	0.000316	0.0023	CcSEcCtD
Amoxapine—Somnolence—Epirubicin—thyroid cancer	0.000313	0.00228	CcSEcCtD
Amoxapine—SLC6A4—head—thyroid cancer	0.000311	0.0283	CbGeAlD
Amoxapine—Anorexia—Doxorubicin—thyroid cancer	0.00031	0.00226	CcSEcCtD
Amoxapine—Dyspepsia—Epirubicin—thyroid cancer	0.000309	0.00226	CcSEcCtD
Amoxapine—CHRM1—head—thyroid cancer	0.000309	0.0282	CbGeAlD
Amoxapine—HTR2B—head—thyroid cancer	0.000308	0.028	CbGeAlD
Amoxapine—Decreased appetite—Epirubicin—thyroid cancer	0.000306	0.00223	CcSEcCtD
Amoxapine—Hypotension—Doxorubicin—thyroid cancer	0.000304	0.00222	CcSEcCtD
Amoxapine—Fatigue—Epirubicin—thyroid cancer	0.000303	0.00221	CcSEcCtD
Amoxapine—Constipation—Epirubicin—thyroid cancer	0.000301	0.00219	CcSEcCtD
Amoxapine—Insomnia—Doxorubicin—thyroid cancer	0.000294	0.00215	CcSEcCtD
Amoxapine—Paraesthesia—Doxorubicin—thyroid cancer	0.000292	0.00213	CcSEcCtD
Amoxapine—Feeling abnormal—Epirubicin—thyroid cancer	0.00029	0.00211	CcSEcCtD
Amoxapine—Somnolence—Doxorubicin—thyroid cancer	0.000289	0.00211	CcSEcCtD
Amoxapine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000287	0.0021	CcSEcCtD
Amoxapine—Dyspepsia—Doxorubicin—thyroid cancer	0.000286	0.00209	CcSEcCtD
Amoxapine—Decreased appetite—Doxorubicin—thyroid cancer	0.000283	0.00206	CcSEcCtD
Amoxapine—Fatigue—Doxorubicin—thyroid cancer	0.00028	0.00205	CcSEcCtD
Amoxapine—HRH1—trachea—thyroid cancer	0.00028	0.0256	CbGeAlD
Amoxapine—Urticaria—Epirubicin—thyroid cancer	0.000279	0.00204	CcSEcCtD
Amoxapine—Constipation—Doxorubicin—thyroid cancer	0.000278	0.00203	CcSEcCtD
Amoxapine—Abdominal pain—Epirubicin—thyroid cancer	0.000278	0.00203	CcSEcCtD
Amoxapine—Body temperature increased—Epirubicin—thyroid cancer	0.000278	0.00203	CcSEcCtD
Amoxapine—HTR1A—head—thyroid cancer	0.000276	0.0251	CbGeAlD
Amoxapine—ADRA2A—trachea—thyroid cancer	0.000275	0.0251	CbGeAlD
Amoxapine—SLC6A2—head—thyroid cancer	0.000273	0.0249	CbGeAlD
Amoxapine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000268	0.00195	CcSEcCtD
Amoxapine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000266	0.00194	CcSEcCtD
Amoxapine—HTR7—head—thyroid cancer	0.000264	0.024	CbGeAlD
Amoxapine—Urticaria—Doxorubicin—thyroid cancer	0.000258	0.00188	CcSEcCtD
Amoxapine—Body temperature increased—Doxorubicin—thyroid cancer	0.000257	0.00188	CcSEcCtD
Amoxapine—Abdominal pain—Doxorubicin—thyroid cancer	0.000257	0.00188	CcSEcCtD
Amoxapine—ORM1—lymph node—thyroid cancer	0.000255	0.0233	CbGeAlD
Amoxapine—ADRA1A—head—thyroid cancer	0.000254	0.0232	CbGeAlD
Amoxapine—Asthenia—Epirubicin—thyroid cancer	0.000252	0.00184	CcSEcCtD
Amoxapine—DRD2—head—thyroid cancer	0.000249	0.0227	CbGeAlD
Amoxapine—Pruritus—Epirubicin—thyroid cancer	0.000249	0.00181	CcSEcCtD
Amoxapine—Diarrhoea—Epirubicin—thyroid cancer	0.000241	0.00175	CcSEcCtD
Amoxapine—HTR2A—trachea—thyroid cancer	0.000234	0.0213	CbGeAlD
Amoxapine—Asthenia—Doxorubicin—thyroid cancer	0.000233	0.0017	CcSEcCtD
Amoxapine—Dizziness—Epirubicin—thyroid cancer	0.000232	0.0017	CcSEcCtD
Amoxapine—Pruritus—Doxorubicin—thyroid cancer	0.00023	0.00168	CcSEcCtD
Amoxapine—Vomiting—Epirubicin—thyroid cancer	0.000224	0.00163	CcSEcCtD
Amoxapine—Diarrhoea—Doxorubicin—thyroid cancer	0.000223	0.00162	CcSEcCtD
Amoxapine—Rash—Epirubicin—thyroid cancer	0.000222	0.00162	CcSEcCtD
Amoxapine—Dermatitis—Epirubicin—thyroid cancer	0.000221	0.00161	CcSEcCtD
Amoxapine—Headache—Epirubicin—thyroid cancer	0.00022	0.00161	CcSEcCtD
Amoxapine—ADRA2A—thyroid gland—thyroid cancer	0.000218	0.0199	CbGeAlD
Amoxapine—HTR2B—lymph node—thyroid cancer	0.000215	0.0196	CbGeAlD
Amoxapine—Dizziness—Doxorubicin—thyroid cancer	0.000215	0.00157	CcSEcCtD
Amoxapine—Nausea—Epirubicin—thyroid cancer	0.000209	0.00152	CcSEcCtD
Amoxapine—Vomiting—Doxorubicin—thyroid cancer	0.000207	0.00151	CcSEcCtD
Amoxapine—Rash—Doxorubicin—thyroid cancer	0.000205	0.0015	CcSEcCtD
Amoxapine—Dermatitis—Doxorubicin—thyroid cancer	0.000205	0.00149	CcSEcCtD
Amoxapine—Headache—Doxorubicin—thyroid cancer	0.000204	0.00149	CcSEcCtD
Amoxapine—HRH1—head—thyroid cancer	0.000197	0.0179	CbGeAlD
Amoxapine—ADRA2A—head—thyroid cancer	0.000193	0.0176	CbGeAlD
Amoxapine—Nausea—Doxorubicin—thyroid cancer	0.000193	0.00141	CcSEcCtD
Amoxapine—SLC6A2—lymph node—thyroid cancer	0.000191	0.0174	CbGeAlD
Amoxapine—HTR2A—head—thyroid cancer	0.000164	0.015	CbGeAlD
Amoxapine—CYP2D6—head—thyroid cancer	0.00015	0.0136	CbGeAlD
Amoxapine—HRH1—lymph node—thyroid cancer	0.000138	0.0126	CbGeAlD
Amoxapine—ADRA2A—lymph node—thyroid cancer	0.000135	0.0123	CbGeAlD
Amoxapine—ADRA2A—Signaling Pathways—CALCA—thyroid cancer	2.87e-05	0.000262	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CDK1—thyroid cancer	2.86e-05	0.000261	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CDK1—thyroid cancer	2.85e-05	0.00026	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CDK1—thyroid cancer	2.84e-05	0.000259	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—HIF1A—thyroid cancer	2.81e-05	0.000257	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CDK1—thyroid cancer	2.8e-05	0.000255	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—TERT—thyroid cancer	2.77e-05	0.000253	CbGpPWpGaD
Amoxapine—ADRA2A—Hemostasis—NRAS—thyroid cancer	2.75e-05	0.000251	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—TERT—thyroid cancer	2.74e-05	0.00025	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—NRAS—thyroid cancer	2.71e-05	0.000248	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—NRAS—thyroid cancer	2.71e-05	0.000247	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—NRAS—thyroid cancer	2.7e-05	0.000246	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—NRG1—thyroid cancer	2.66e-05	0.000242	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—HIF1A—thyroid cancer	2.65e-05	0.000242	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—NRG1—thyroid cancer	2.64e-05	0.000241	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—NRAS—thyroid cancer	2.64e-05	0.000241	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—HIF1A—thyroid cancer	2.62e-05	0.000239	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CDK1—thyroid cancer	2.6e-05	0.000237	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—NRAS—thyroid cancer	2.6e-05	0.000237	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—BRAF—thyroid cancer	2.55e-05	0.000233	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—BRAF—thyroid cancer	2.55e-05	0.000233	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—BRAF—thyroid cancer	2.48e-05	0.000226	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—NRAS—thyroid cancer	2.48e-05	0.000226	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—BRAF—thyroid cancer	2.44e-05	0.000223	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—TERT—thyroid cancer	2.39e-05	0.000218	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—TERT—thyroid cancer	2.37e-05	0.000216	CbGpPWpGaD
Amoxapine—ADRA2A—Hemostasis—KRAS—thyroid cancer	2.37e-05	0.000216	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—NRAS—thyroid cancer	2.34e-05	0.000213	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—KRAS—thyroid cancer	2.34e-05	0.000213	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—KRAS—thyroid cancer	2.33e-05	0.000213	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—NRG1—thyroid cancer	2.33e-05	0.000213	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—BRAF—thyroid cancer	2.33e-05	0.000212	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—KRAS—thyroid cancer	2.32e-05	0.000212	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—NRAS—thyroid cancer	2.31e-05	0.00021	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—NRG1—thyroid cancer	2.3e-05	0.000209	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—NRG1—thyroid cancer	2.29e-05	0.000209	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—NRG1—thyroid cancer	2.28e-05	0.000208	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—HIF1A—thyroid cancer	2.28e-05	0.000208	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—KRAS—thyroid cancer	2.27e-05	0.000207	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—HIF1A—thyroid cancer	2.27e-05	0.000207	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—NRG1—thyroid cancer	2.25e-05	0.000205	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—SLC5A5—thyroid cancer	2.24e-05	0.000204	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—KRAS—thyroid cancer	2.23e-05	0.000204	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—BRAF—thyroid cancer	2.2e-05	0.0002	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—BRAF—thyroid cancer	2.17e-05	0.000198	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—KRAS—thyroid cancer	2.13e-05	0.000195	CbGpPWpGaD
Amoxapine—ADRA2A—Hemostasis—TP53—thyroid cancer	2.11e-05	0.000192	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TERT—thyroid cancer	2.09e-05	0.000191	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—NRG1—thyroid cancer	2.09e-05	0.00019	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—TP53—thyroid cancer	2.06e-05	0.000188	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TERT—thyroid cancer	2.06e-05	0.000188	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TERT—thyroid cancer	2.06e-05	0.000188	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TERT—thyroid cancer	2.05e-05	0.000187	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TERT—thyroid cancer	2.02e-05	0.000184	CbGpPWpGaD
Amoxapine—ADRA2A—Hemostasis—HRAS—thyroid cancer	2.01e-05	0.000184	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—KRAS—thyroid cancer	2.01e-05	0.000183	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—NRAS—thyroid cancer	2.01e-05	0.000183	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—HIF1A—thyroid cancer	2e-05	0.000183	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—NRAS—thyroid cancer	2e-05	0.000182	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—HRAS—thyroid cancer	1.99e-05	0.000181	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—KRAS—thyroid cancer	1.98e-05	0.000181	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—HRAS—thyroid cancer	1.98e-05	0.000181	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—HRAS—thyroid cancer	1.97e-05	0.00018	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—HIF1A—thyroid cancer	1.97e-05	0.00018	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—HIF1A—thyroid cancer	1.97e-05	0.000179	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—HIF1A—thyroid cancer	1.96e-05	0.000179	CbGpPWpGaD
Amoxapine—HTR6—GPCR downstream signaling—AKT1—thyroid cancer	1.93e-05	0.000176	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—HRAS—thyroid cancer	1.93e-05	0.000176	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—HIF1A—thyroid cancer	1.93e-05	0.000176	CbGpPWpGaD
Amoxapine—HTR7—GPCR downstream signaling—AKT1—thyroid cancer	1.93e-05	0.000176	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—HRAS—thyroid cancer	1.9e-05	0.000173	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—BRAF—thyroid cancer	1.89e-05	0.000172	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—RXRA—thyroid cancer	1.88e-05	0.000172	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—BRAF—thyroid cancer	1.88e-05	0.000171	CbGpPWpGaD
Amoxapine—HTR1B—GPCR downstream signaling—AKT1—thyroid cancer	1.88e-05	0.000171	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TERT—thyroid cancer	1.87e-05	0.000171	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—CCND1—thyroid cancer	1.86e-05	0.00017	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—CCND1—thyroid cancer	1.86e-05	0.00017	CbGpPWpGaD
Amoxapine—DRD4—GPCR downstream signaling—AKT1—thyroid cancer	1.85e-05	0.000168	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—PPARG—thyroid cancer	1.82e-05	0.000166	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—HRAS—thyroid cancer	1.81e-05	0.000165	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—CCND1—thyroid cancer	1.81e-05	0.000165	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—PTEN—thyroid cancer	1.8e-05	0.000164	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—PTEN—thyroid cancer	1.8e-05	0.000164	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—HIF1A—thyroid cancer	1.79e-05	0.000164	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—CCND1—thyroid cancer	1.78e-05	0.000162	CbGpPWpGaD
Amoxapine—ADRA2A—Hemostasis—AKT1—thyroid cancer	1.78e-05	0.000162	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—NRAS—thyroid cancer	1.76e-05	0.000161	CbGpPWpGaD
Amoxapine—HTR2B—GPCR downstream signaling—AKT1—thyroid cancer	1.76e-05	0.000161	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—AKT1—thyroid cancer	1.75e-05	0.00016	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—AKT1—thyroid cancer	1.75e-05	0.00016	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—PTEN—thyroid cancer	1.75e-05	0.000159	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—AKT1—thyroid cancer	1.74e-05	0.000159	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—NRAS—thyroid cancer	1.74e-05	0.000158	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—NRAS—thyroid cancer	1.73e-05	0.000158	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—KRAS—thyroid cancer	1.73e-05	0.000158	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—NRAS—thyroid cancer	1.73e-05	0.000158	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—KRAS—thyroid cancer	1.72e-05	0.000157	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—PTEN—thyroid cancer	1.72e-05	0.000157	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—HRAS—thyroid cancer	1.71e-05	0.000156	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—AKT1—thyroid cancer	1.7e-05	0.000155	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—CCND1—thyroid cancer	1.7e-05	0.000155	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—NRAS—thyroid cancer	1.7e-05	0.000155	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—HRAS—thyroid cancer	1.69e-05	0.000154	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—AKT1—thyroid cancer	1.68e-05	0.000153	CbGpPWpGaD
Amoxapine—DRD1—GPCR downstream signaling—AKT1—thyroid cancer	1.66e-05	0.000152	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—BRAF—thyroid cancer	1.66e-05	0.000151	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—PTEN—thyroid cancer	1.64e-05	0.00015	CbGpPWpGaD
Amoxapine—DRD3—GPCR downstream signaling—AKT1—thyroid cancer	1.64e-05	0.00015	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—BRAF—thyroid cancer	1.63e-05	0.000149	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—BRAF—thyroid cancer	1.63e-05	0.000149	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—BRAF—thyroid cancer	1.62e-05	0.000148	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—NRAS—thyroid cancer	1.6e-05	0.000146	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CCND1—thyroid cancer	1.6e-05	0.000146	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—NRAS—thyroid cancer	1.6e-05	0.000146	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—AKT1—thyroid cancer	1.6e-05	0.000146	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—BRAF—thyroid cancer	1.6e-05	0.000146	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CCND1—thyroid cancer	1.58e-05	0.000144	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—NRAS—thyroid cancer	1.58e-05	0.000144	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—NRAS—thyroid cancer	1.56e-05	0.000142	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—PTEN—thyroid cancer	1.55e-05	0.000141	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—NRAS—thyroid cancer	1.53e-05	0.00014	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—PTEN—thyroid cancer	1.53e-05	0.000139	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—KRAS—thyroid cancer	1.52e-05	0.000139	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—AKT1—thyroid cancer	1.51e-05	0.000138	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—KRAS—thyroid cancer	1.49e-05	0.000136	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—KRAS—thyroid cancer	1.49e-05	0.000136	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—AKT1—thyroid cancer	1.49e-05	0.000136	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—KRAS—thyroid cancer	1.49e-05	0.000136	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—BRAF—thyroid cancer	1.48e-05	0.000135	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—HRAS—thyroid cancer	1.47e-05	0.000134	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—NRAS—thyroid cancer	1.46e-05	0.000134	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—KRAS—thyroid cancer	1.46e-05	0.000133	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—HRAS—thyroid cancer	1.46e-05	0.000133	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—PTGS2—thyroid cancer	1.43e-05	0.000131	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—AKT1—thyroid cancer	1.43e-05	0.00013	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—AKT1—thyroid cancer	1.42e-05	0.00013	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—NRAS—thyroid cancer	1.38e-05	0.000126	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—KRAS—thyroid cancer	1.38e-05	0.000126	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—KRAS—thyroid cancer	1.38e-05	0.000126	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CCND1—thyroid cancer	1.38e-05	0.000126	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CCND1—thyroid cancer	1.37e-05	0.000125	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—NRAS—thyroid cancer	1.36e-05	0.000124	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—KRAS—thyroid cancer	1.36e-05	0.000124	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—KRAS—thyroid cancer	1.34e-05	0.000122	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—PTEN—thyroid cancer	1.33e-05	0.000121	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—PTEN—thyroid cancer	1.32e-05	0.000121	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—KRAS—thyroid cancer	1.32e-05	0.00012	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—AKT1—thyroid cancer	1.3e-05	0.000118	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—AKT1—thyroid cancer	1.29e-05	0.000118	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—HRAS—thyroid cancer	1.29e-05	0.000118	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—HRAS—thyroid cancer	1.27e-05	0.000116	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—HRAS—thyroid cancer	1.27e-05	0.000116	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—HRAS—thyroid cancer	1.26e-05	0.000115	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—KRAS—thyroid cancer	1.26e-05	0.000115	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—AKT1—thyroid cancer	1.26e-05	0.000114	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—PTEN—thyroid cancer	1.25e-05	0.000114	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—HRAS—thyroid cancer	1.24e-05	0.000113	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—AKT1—thyroid cancer	1.24e-05	0.000113	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—AKT1—thyroid cancer	1.23e-05	0.000112	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—AKT1—thyroid cancer	1.23e-05	0.000112	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—TP53—thyroid cancer	1.23e-05	0.000112	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—TP53—thyroid cancer	1.23e-05	0.000112	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CCND1—thyroid cancer	1.21e-05	0.00011	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—AKT1—thyroid cancer	1.21e-05	0.00011	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—TP53—thyroid cancer	1.19e-05	0.000109	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CCND1—thyroid cancer	1.19e-05	0.000109	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CCND1—thyroid cancer	1.19e-05	0.000108	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—KRAS—thyroid cancer	1.19e-05	0.000108	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PPARG—thyroid cancer	1.19e-05	0.000108	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—NRAS—thyroid cancer	1.19e-05	0.000108	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CCND1—thyroid cancer	1.18e-05	0.000108	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—NRAS—thyroid cancer	1.18e-05	0.000108	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—HRAS—thyroid cancer	1.17e-05	0.000107	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—TP53—thyroid cancer	1.17e-05	0.000107	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—KRAS—thyroid cancer	1.17e-05	0.000107	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—HRAS—thyroid cancer	1.17e-05	0.000107	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—PTEN—thyroid cancer	1.17e-05	0.000107	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CCND1—thyroid cancer	1.17e-05	0.000106	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—HRAS—thyroid cancer	1.16e-05	0.000105	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—PTEN—thyroid cancer	1.15e-05	0.000105	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—PTEN—thyroid cancer	1.15e-05	0.000105	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—PTEN—thyroid cancer	1.14e-05	0.000104	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—HRAS—thyroid cancer	1.14e-05	0.000104	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—AKT1—thyroid cancer	1.14e-05	0.000104	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—PTEN—thyroid cancer	1.13e-05	0.000103	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—AKT1—thyroid cancer	1.12e-05	0.000102	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—HRAS—thyroid cancer	1.12e-05	0.000102	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—AKT1—thyroid cancer	1.12e-05	0.000102	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—TP53—thyroid cancer	1.12e-05	0.000102	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—AKT1—thyroid cancer	1.12e-05	0.000102	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—AKT1—thyroid cancer	1.12e-05	0.000102	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—AKT1—thyroid cancer	1.1e-05	0.0001	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CCND1—thyroid cancer	1.08e-05	9.88e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—HRAS—thyroid cancer	1.07e-05	9.77e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—TP53—thyroid cancer	1.06e-05	9.63e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—PTEN—thyroid cancer	1.05e-05	9.54e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—NRAS—thyroid cancer	1.04e-05	9.51e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—TP53—thyroid cancer	1.04e-05	9.5e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—AKT1—thyroid cancer	1.04e-05	9.45e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—AKT1—thyroid cancer	1.03e-05	9.44e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—NRAS—thyroid cancer	1.03e-05	9.36e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—NRAS—thyroid cancer	1.02e-05	9.34e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—KRAS—thyroid cancer	1.02e-05	9.32e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—AKT1—thyroid cancer	1.02e-05	9.31e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—NRAS—thyroid cancer	1.02e-05	9.31e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—KRAS—thyroid cancer	1.02e-05	9.27e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—HRAS—thyroid cancer	1.01e-05	9.21e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—AKT1—thyroid cancer	1.01e-05	9.18e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—NRAS—thyroid cancer	1e-05	9.16e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—HRAS—thyroid cancer	9.97e-06	9.09e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—AKT1—thyroid cancer	9.91e-06	9.04e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—AKT1—thyroid cancer	9.46e-06	8.63e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PTGS2—thyroid cancer	9.35e-06	8.52e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—NRAS—thyroid cancer	9.33e-06	8.51e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—TP53—thyroid cancer	9.08e-06	8.28e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—TP53—thyroid cancer	9.03e-06	8.24e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—KRAS—thyroid cancer	8.97e-06	8.18e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—AKT1—thyroid cancer	8.92e-06	8.13e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—KRAS—thyroid cancer	8.83e-06	8.05e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—KRAS—thyroid cancer	8.81e-06	8.03e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—AKT1—thyroid cancer	8.8e-06	8.03e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—KRAS—thyroid cancer	8.78e-06	8.01e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—HRAS—thyroid cancer	8.69e-06	7.92e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—KRAS—thyroid cancer	8.64e-06	7.88e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—HRAS—thyroid cancer	8.64e-06	7.88e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PTEN—thyroid cancer	8.15e-06	7.43e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—KRAS—thyroid cancer	8.03e-06	7.33e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TP53—thyroid cancer	7.97e-06	7.27e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TP53—thyroid cancer	7.85e-06	7.16e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TP53—thyroid cancer	7.83e-06	7.14e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TP53—thyroid cancer	7.8e-06	7.12e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TP53—thyroid cancer	7.68e-06	7.01e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—AKT1—thyroid cancer	7.67e-06	7e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—AKT1—thyroid cancer	7.63e-06	6.96e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—HRAS—thyroid cancer	7.63e-06	6.96e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—HRAS—thyroid cancer	7.5e-06	6.84e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—HRAS—thyroid cancer	7.49e-06	6.83e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—HRAS—thyroid cancer	7.46e-06	6.81e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—HRAS—thyroid cancer	7.35e-06	6.7e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—AKT1—thyroid cancer	7.21e-06	6.58e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TP53—thyroid cancer	7.14e-06	6.51e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—HRAS—thyroid cancer	6.83e-06	6.23e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—AKT1—thyroid cancer	6.73e-06	6.14e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—AKT1—thyroid cancer	6.63e-06	6.04e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—AKT1—thyroid cancer	6.61e-06	6.03e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—AKT1—thyroid cancer	6.59e-06	6.01e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—AKT1—thyroid cancer	6.49e-06	5.92e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—AKT1—thyroid cancer	6.03e-06	5.5e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—AKT1—thyroid cancer	4.7e-06	4.28e-05	CbGpPWpGaD
